U.S., March 10 -- ClinicalTrials.gov registry received information related to the study (NCT07459062) titled 'Spectral Cancer Tissue Recognition - I' on March 03.
Brief Summary: This analytical performance study aims to validate the SPCTRone system for use in breast conserving surgery of breast cancer patients. By collecting spectral biomarkers and correlating these with the golden standard of histopathological assessment by a pathologist, we aim to train and optimize an AI model that is able to achieve the following outcomes with classifying tissues:
* Sensitivity (percentage of classified positive margins of actual positive margins): >= 96% CI 95.5-97.5%
* Specificity (percentage of classified free margins of actual free margins): 96% ...